NCT07200414 2026-04-13
SHARP
Johns Hopkins Bloomberg School of Public Health
Phase NA Completed
Clinical Trials
11 trialsNCT03903562 2026-04-06
V503-024
Merck Sharp & Dohme LLC
Phase 3 Completed
NCT06919627 2026-04-02
PaPCR
University Hospital, Brest
Completed
NCT06784960 2026-03-30
Communication Strategies to Increase HPV Vaccination Intention
University of Pennsylvania
Phase NA Completed
NCT06738355 2026-03-20
PREVENT Pilot HPV - Related Cancers Trial
University of Utah
Phase NA Completed
NCT02858310 2026-03-09
E7 TCR T Cells for Human Papillomavirus-Associated Cancers
National Institutes of Health Clinical Center (CC)
Phase 1/2 Completed
NCT01932697 2026-02-10
Radiation Therapy and Docetaxel in Treating Patients With HPV-Related Oropharyngeal Cancer
Mayo Clinic
Phase 2 Completed
NCT05119855 2026-02-05
Safety and Immunogenicity of 9-valent Human Papillomavirus (9vHPV) Vaccine Coadministered With Messenger Ribonucleic Acid (mRNA)-1273 Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) (COVID-19) Vaccine (V503-076)
Merck Sharp & Dohme LLC
Phase 3 Completed
NCT06752083 2026-01-28
Efficacy of Lentinula Edodes-Derived Supplement (AHCC®) in Promoting Negativity of Persistent HPV Infection
Liaquat University of Medical & Health Sciences
Completed
NCT05524025 2026-01-21
The SPOT-HPV Study
Dana-Farber Cancer Institute
Completed
NCT07244315 2026-01-21
Cervical Cancer Screening of Postmenopausal Women in Low- and Middle-income Countries Using HPV Self-sampling and Triage by Genotyping and Cytology
University Hospital, Geneva
Completed